>>> US Research Calls I

Research Calls I
  • Upgrades:
    • Cincinnati Fincl (CINF) upgraded to Buy from Neutral at Citigroup; tgt raised to $135
    • Digital Realty Trust (DLR) upgraded to Overweight from Neutral at JP Morgan; tgt raised to $175
    • Equity Residential (EQR) upgraded to Overweight from Neutral at Piper Sandler; tgt raised to $80
    • Guardant Health (GH) upgraded to Buy from Neutral at Guggenheim; tgt $36
    • Int'l Paper (IP) upgraded to Buy from Neutral at Seaport Research Partners; tgt $52
  • Downgrades:
    • Acuity Brands (AYI) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $260
    • Alphabet (GOOG/L) downgraded to Neutral from Buy at Rosenblatt; tgt $181
    • American Fincl (AFG) downgraded to Neutral from Buy at Citigroup; tgt lowered to $137
    • Chubb (CB) downgraded to Underperform from Mkt Perform at William Blair
    • Hartford Financial (HIG) downgraded to Neutral from Buy at Citigroup; tgt lowered to $114
  • Others:
    • Addus HomeCare (ADUS) initiated with an Outperform at Macquarie; tgt $136
    • Affirm (AFRM) initiated with a Mkt Perform at JMP Securities
    • AGCO Corp (AGCO) initiated with a Mkt Perform at Raymond James
    • Allison Transmission (ALSN) initiated with an Outperform at Raymond James; tgt $85
    • Amcor (AMCR) initiated with an Equal Weight at Wells Fargo; tgt $9.80
    • Array Tech (ARRY) initiated with a Positive at Susquehanna; tgt $14
    • Brookdale Senior Living (BKD) initiated with an Outperform at Macquarie; tgt $7.50
    • Caterpillar (CAT) initiated with a Mkt Perform at Raymond James
    • CG Oncology (CGON) initiated with a Buy at BofA Securities; tgt $65
    • CNH Industrial (CNH) initiated with a Mkt Perform at Raymond James
    • CRISPR Therapeutics (CRSP) resumed with a Neutral at Guggenheim
    • Cummins (CMI) initiated with a Mkt Perform at Raymond James
    • Deere (DE) initiated with an Outperform at Raymond James; tgt $420
    • Donaldson (DCI) initiated with a Mkt Perform at Raymond James
    • Eaton (ETN) initiated with an Outperform at Raymond James; tgt $375
    • Ensign Group (ENSG) initiated with an Outperform at Macquarie; tgt $134
    • Essential Properties Realty Trust (EPRT) initiated with a Buy at Goldman; tgt $33
    • First Comm Banc (FCBC) initiated with a Market Perform at Hovde Group; tgt $38
    • H&E Equipment (HEES) initiated with a Mkt Perform at Raymond James
    • Intuitive Machines (LUNR) initiated with a Buy at B. Riley Securities; tgt $8
    • Journey Medical (DERM) resumed with a Buy at ROTH MKM; tgt $11
    • Madrigal Pharmaceuticals (MDGL) initiated with a Neutral at Cantor Fitzgerald

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:
  • ACCD -29.3%, NKE -14.9%, KRUS -10.2%
Other news:
  • PTCT -13.4% (CHMP issues Negative Opinion on Translarna following European Commission request for review)
  • APLS -4.7% (confirms it plans to seek re-examination following negative CHMP opinion for pegcetacoplan for geographic atrophy in the EU)
  • FL -4.5% (in sympathy with weak Nike earnings)
  • SKX -4.1% (in sympathy with weak Nike earnings)
  • CCCS -2.6% (prices secondary offering of 30 mln shares of common stock)
  • UAA -2.6% (in sympathy with weak Nike earnings)
  • ONON -2.5% (in sympathy with weak Nike earnings)
  • DKS -1.8% (in sympathy with weak Nike earnings)
  • GMAB -1.4% (receives Positive CHMP Opinion for Epcoritamab)
  • DECK -1.2% (in sympathy with weak Nike earnings)

>>> US Gapping up

Gapping up
News:
  • ESPR +23.4% (announces monetization of European royalties and concurrent payoff and termination of existing revenue interest facility)
  • INFN +19% (NOK to acquire INFN)
  • PTGX +10.3% (to join S&P SmallCap 600)
  • CANF +6.6% (reports results from Osteoarthritis Clinical Study in Dogs reported by Can-Fite's Partner Vetbiolix)
  • SPRY +6.1% (announces EURneffy (adrenaline nasal spray) recommended for approval by CHMP for emergency treatment of allergic reactions)
  • LWAY +5.9% (to dismiss its claims against PCO)
  • TIGO +4.7% (Independent committee of Millicom board believes anticipated takeover offer by Atlas at a price of $24/share would significantly undervalue Millicom in light of expected financial performance)
  • ELYM +4.6% (closes its acquisition with Tenet Medicines; announces related $120 mln private placement)
  • EBR +3.7% (signed a Memorandum of Understanding with Suzano (SUZ) for the development of sustainable solutions based on the use of biogenic CO2 generated in Suzano units)
  • PLUG +3.3% (to receive Federal Clean Hydrogen Production Tax Credit at Georgia Hydrogen Facility)
  • MRNA +1.5% (Carisma Therapeutics (CARM) announces nomination of first in Vivo CAR-M development candidate for hepatocellular carcinoma under collaboration with MRNA)
  • SMCI +1.5% (Barron's out positive on SMCI)
  • COIN +1.2% (COIN partners with Stripe to expand global adoption of crypto)
  • IMMP +1.1% (reports positive topline results from TACTI-003 Phase IIb Trial in first line head and neck cancer)
  • TNYA +1% (announces research leadership updates)

>>> US Early premarket gappers

Early premarket gappers
  • Gapping up:
    • INFN +17.1%, PTGX +10.6%, LWAY +5%, ELYM +4.6%, TIGO +4.4%, EBR +3.7%, NOK +1.3%, TNYA +1%, GXO +0.8%, COIN +0.6%, GD +0.5%, LMT +0.5%, UBER +0.5%, BIIB +0.5%, ABBV +0.5%
  • Gapping down:
    • ACCD -25.2%, NKE -14.6%, KRUS -7.8%, PTCT -6.1%, FL -5%, DVAX -3.3%, UAA -3.1%, ONON -2.7%, SKX -2.7%, LDOS -2%, CCCS -1.7%, DKS -1.2%, DECK -1%

FT : BBVA’s hostile bid for Sabadell is ‘unstoppable’, claims chair

BBVA’s hostile bid for Sabadell is ‘unstoppable’, claims chair
Carlos Torres is confident the Spanish bank’s €10bn pursuit of its smaller rival will succeed

The chair of Spanish bank BBVA has declared that its hostile bid for rival Sabadell is “unstoppable” and should have little trouble overcoming regulatory or political challenges.

The biggest European banking deal of the year is entering a crucial stage, with BBVA shareholders due to vote on raising additional capital to support the €10bn all-share tender offer at an emergency meeting next week. 

In an interview with the Financial Times, BBVA executive chair Carlos Torres said the Sabadell board had been wrong to reject his bank’s friendly approach last month. “They say it’s about the economics . . . but I think they’re kidding themselves,” he said. 

“They have that self-confidence and they believe that they can continue to create value and maybe integrating with BBVA they might view as a bit of a cold shower. I can empathise with that, but it’s not the right answer.”

He added: “This is a great offer. It’s a knockout offer. It’s an amazingly rich offer.” 

If the vote on BBVA raising additional capital is approved, the bank must then wait for European and Spanish regulators to give its takeover bid the green light or demand any remedies to address competition concerns.

The next stage would be to open the tender offer to Sabadell shareholders, who must sell more than 50 per cent of the smaller lender’s shares for BBVA to succeed in its pursuit.

The final step in the process comes with complications: Spain’s Socialist-led government must rule on the merger of the two entities and has said it will veto the tie-up even if BBVA already owns Sabadell. Even if BBVA prevails, the deal is unlikely to be completed until mid-2025.

Torres first approached Josep Oliu, his opposite number at Sabadell, in mid-April and the offer is based on a 50 per cent premium on Sabadell’s share price at that point. Since then, Sabadell’s shares have risen 28 per cent and BBVA’s have dropped 6 per cent, reducing the premium to just 7 per cent.

The BBVA chair said Sabadell’s share price rise reflected investor expectation that his bank’s bid would succeed.

However, a person close to Sabadell said the long bidding process made that outcome uncertain.

“The overwhelming opposition to the transaction from almost every stakeholder group shows this is far from a done deal,” they added. “The impact of any transaction on competition in an already concentrated market in Spain is front of mind for stakeholders.”

Proxy advisers ISS, Glass Lewis, Corporance and Pirc have all recommended BBVA investors vote in favour of the capital increase at next Friday’s EGM, though each qualified their support by saying the hostile bid — a rare move in Spain — created uncertainties around the deal being completed.

Torres said he had received support from BBVA’s shareholders for the takeover, including those investors that also held stakes in Sabadell. “The value of Sabadell is relying entirely on the value of our offer,” he said

The next stage in the process would be for the European Central Bank and Spain’s market regulator to give their approval, which is expected as no solvency issues are involved.

Spain’s antitrust watchdog must also weigh in on the deal and Torres said he expected that any amendments requested for competition reasons would be acceptable.

Carlos Cuerpo, Spain’s economy minister, has however listed competition issues among the government’s concerns, along with worries over employment, financial stability and even Spain’s “territorial cohesion”.

While the government has the final say on the merger, Torres said: “We’re confident that we can work together in addressing those concerns.”

“The transaction makes sense for Spain, for Europe,” he added, pointing out that just two of the world’s 20 biggest banks by market capitalisation were from Europe — HSBC and UBS — and neither of which were in the EU. 

“That’s why we’re quite confident this is a train that’s unstoppable and this will happen. Not just because it’s good for shareholders, but it’s good for clients and it’s good for society as well,” he said.

>>> Europe : Brokers Upgrades & Downgrades - 28th of June 2024 V2(+)

>>> Up
* Antin Raised to Buy at Citi; PT 15.60 euros
* Intertek Raised to Buy at Goldman; PT 6,350 pence
* Melia Hotels Raised to Buy at Bestinver; PT 9.10 euros (+)

>>> Down
* Air France-KLM Cut to Equal-Weight at Barclays; PT 9.50 euros
* Fortum Cut to Sell at Goldman; PT 14.30 euros
* Gjensidige Cut to Hold at Arctic Securities; PT 200 kroner (+)
* Kitron Cut to Hold at Norne Securities; PT 34 kroner
* Liontrust Cut to Hold at Peel Hunt; PT 750 pence
* Nike Cut to Hold at Stifel; PT $88
* Nike Cut to Equal-Weight at Morgan Stanley; PT $79
* Safestore Cut to Equal-Weight at Morgan Stanley; PT 850 pence
* Tele2 Cut to Hold at ABG; PT 110 kronor
* Terna Cut to Sell at Goldman; PT 7.60 euros
* Walgreens Boots PT Cut to $13 from $22 at Deutsche Bank (+)

>>> Initiation
* Avon Protection Rated New Equal-Weight at Barclays
* Barclays Rated New Hold at Intesa Sanpaolo; PT 230 pence (+)
* BASF ADRs Rated New Buy at Berenberg; PT $14.40
* Brembo Rated New Buy at Deutsche Bank; PT 13 euros (+)
* CNH Industrial Rated New Market Perform at Raymond James
* Lloyds Rated New Hold at Intesa Sanpaolo; PT 62 pence (+)
* NatWest Rated New Buy at Intesa Sanpaolo; PT 380 pence (+)

>>> Call
* Air France-KLM Downgraded at Barclays on French Political Risk (+)

>>> Stoxx 600 Pre-Market Indications

  • Eurofins Scientific (ESF0 TH) +1.1%
  • Engie (GZF TH) +1%
    • Masdar, Engie, Total to Bid for Brookfield’s Saeta: Cinco
  • Zalando (ZAL TH) -2.2%
  • Nokia (NOA3 TH) -2.3%
    • Nokia Is Said to Explore Deal for US Networking Company Infinera
  • Adidas (ADS TH) -2.7%
    • Watch Nike’s European Peers as It Warns of Worsening Sales Drop
  • Delivery Hero (DHER TH) -2.8%
    • Delivery Hero Appoints Marie-Anne Popp as Interim CFO
  • Puma (PUM TH) -4.2%
    • Watch Nike’s European Peers as It Warns of Worsening Sales Drop
  • JD Sports (9JD TH) -8.2%
    • Watch Nike’s European Peers as It Warns of Worsening Sales Drop

>>> TradeGate Pre-Market Indications

DAX:
  • Zalando (ZAL TH) -2%
  • Adidas (ADS TH) -2.6%
    • Watch Nike’s European Peers as It Warns of Worsening Sales Drop
MDAX:
  • HelloFresh (HFG TH) +1%
  • Delivery Hero (DHER TH) -1.1%
    • Delivery Hero Appoints Marie-Anne Popp as Interim CFO
  • Puma (PUM TH) -3.6%
    • Watch Nike’s European Peers as It Warns of Worsening Sales Drop
SDAX:
  • Deutz (DEZ TH) +1.8%
    • Deutz to Acquire Blue Star Power Systems, No Terms
  • Borussia Dortmund (BVB TH) +1%
  • Cancom (COK TH) -1%
  • MLP (MLP TH) -3.7%
  • Deutsche Beteiligungs (DBAN TH) -6.7%